Literature DB >> 21263447

Cancer genetics: Initially complex, always heterogeneous.

Darren J Burgess.   

Abstract

Entities:  

Year:  2011        PMID： 21263447     DOI： 10.1038/nrg2965

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN： 1471-0056            Impact factor:   53.242


× No keyword cloud information.
  2 in total

1.  Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

Authors:  Faiyaz Notta; Charles G Mullighan; Jean C Y Wang; Armando Poeppl; Sergei Doulatov; Letha A Phillips; Jing Ma; Mark D Minden; James R Downing; John E Dick
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

2.  Genetic variegation of clonal architecture and propagating cells in leukaemia.

Authors:  Kristina Anderson; Christoph Lutz; Frederik W van Delft; Caroline M Bateman; Yanping Guo; Susan M Colman; Helena Kempski; Anthony V Moorman; Ian Titley; John Swansbury; Lyndal Kearney; Tariq Enver; Mel Greaves
Journal:  Nature       Date:  2010-12-15       Impact factor: 49.962
  2 in total
  3 in total

Review 1.  Control dominating subclones for managing cancer progression and posttreatment recurrence by subclonal switchboard signal: implication for new therapies.

Authors:  Shengwen Calvin Li; Katherine L Lee; Jane Luo
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

2.  In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer.

Authors:  Xiao Ling Ni; Long Xia Chen; Heng Zhang; Bo Yang; Shan Xu; Min Wu; Jing Liu; Ling Lin Yang; Yue Chen; Shao Zhi Fu; Jing Bo Wu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia.

Authors:  S P Boudreaux; A M Ramirez-Herrick; R P Duren; O M Conneely
Journal:  Oncogenesis       Date:  2012-07-02       Impact factor: 7.485
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.